Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Sep 05, 2011 12:18 PM

Start: Nov 03, 2011 05:15 PM

[image reference is broken]

Speaker: Andy Phillipps, Chairman, Reevoo
Andy Phillipps was co-founder and CEO of Active Hotels, which he helped to grow to become the largest on-line hotel booking company in Europe.

The company was recognised as the fastest growing technology company in the UK by Deloitte, was a Sunday Times best employer and Andy won Emerging Entrepreneur of the Year.

Find out more >>